Romosozumab Treatment After Parathyroidectomy for Primary Hyperparathyroidism-Complicated Osteoporosis: A Two-Case Report
AACE Endocrinology and Diabetes · 2026-07 · 13 (4) · 657-661
DOI: 10.1016/j.aed.2026.04.008 ↗Kurz gefasst
Fallbericht in der Zeitschrift AACE Endocrinology and Diabetes, 2026-07. Verfasst von Saya Takebe und 4 weiteren Autor:innen. Beteiligte Einrichtung: Division of Hormonal Medicine and Bioregulatory Science, Department of Medicine, Tokyo Women's Medical University, Tokyo, Japan. Die Arbeit nennt 20 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Division of Hormonal Medicine and Bioregulatory Science, Department of Medicine, Tokyo Women's Medical University, Tokyo, Japan.
- Department of Medicine, Tokyo Women's Medical University Adachi Medical Center, Tokyo, Japan.
Zitieren
APA
Takebe, S., Seki, Y., Morimoto, S., Watanabe, D., & Ichihara, A. (2026). Romosozumab Treatment After Parathyroidectomy for Primary Hyperparathyroidism-Complicated Osteoporosis: A Two-Case Report. AACE Endocrinology and Diabetes, 13(4), 657-661. https://doi.org/10.1016/j.aed.2026.04.008
Vancouver
Takebe S, Seki Y, Morimoto S, Watanabe D, Ichihara A. Romosozumab Treatment After Parathyroidectomy for Primary Hyperparathyroidism-Complicated Osteoporosis: A Two-Case Report. AACE Endocrinology and Diabetes. 2026;13(4):657-661. doi:10.1016/j.aed.2026.04.008
BibTeX
@article{Takebe2026,
author = {Takebe, Saya and Seki, Yasufumi and Morimoto, Satoshi and Watanabe, Daisuke and Ichihara, Atsuhiro},
title = {Romosozumab Treatment After Parathyroidectomy for Primary Hyperparathyroidism-Complicated Osteoporosis: A Two-Case Report},
journal = {AACE Endocrinology and Diabetes},
year = {2026},
volume = {13},
number = {4},
pages = {657--661},
doi = {10.1016/j.aed.2026.04.008}
}
EUVIMED